Amoeba – executive interview

Amoeba – executive interview

Amoeba — 1 video in collection

More on this equity

Amoeba is developing biological fungicides for treating diseases such as mildews and rusts, which have a major economic impact on the production globally of a wide range of crops including vines, potatoes, vegetables, cereals and bananas. These novel fungicides are based on the characteristics of the Willaertia magna C2c Maky amoeba.

In this interview, Amoeba CEO and chairman Fabrice Plasson explains why there is so much interest in biological alternatives to conventional crop protection products at present and describes both the progress the company has made so far in commercialising its biofungicides and the additional steps required before Amoeba starts to generate revenues from this technology.

You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free